---
title: "Tigermed plans sale of Frontage's overseas laboratory business to Charles River, Song Li"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/304846406.md"
description: "Tigermed plans to privatize its subsidiary Frontage Holdings. Post-restructuring, Frontage's overseas laboratory business will be sold to Charles River Laboratories and Chairman Song Li, while retaining the China business to focus on clinical contract research services. The transaction aims to generate proceeds for reinvestment in core operations, pending standard conditions."
datetime: "2026-11-09T11:53:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/304846406.md)
  - [en](https://longbridge.com/en/news/304846406.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/304846406.md)
generator: "portal-rs"
---

# Tigermed plans sale of Frontage's overseas laboratory business to Charles River, Song Li

-   Tigermed proposes to participate in the privatization of controlled subsidiary Frontage Holdings through wholly owned Hongkong Tigermed. \* A subsequent restructuring would sell Frontage’s overseas laboratory services business to Charles River Laboratories, Frontage Chairman Song Li and his trusts. \* Frontage’s China business would be retained, strengthening the group’s focus on clinical contract research services. \* The transaction is expected to generate proceeds and investment gains for potential reinvestment in the core clinical research business. \* Completion remains subject to relevant conditions and implementation requirements. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Tigermed Consulting Co. Ltd. published the original content used to generate this news brief on November 09, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CRL.US](https://longbridge.com/en/quote/CRL.US.md)
- [01521.HK](https://longbridge.com/en/quote/01521.HK.md)
- [03347.HK](https://longbridge.com/en/quote/03347.HK.md)
- [300347.CN](https://longbridge.com/en/quote/300347.CN.md)

## Related News & Research

- [Hangzhou Tigermed releases audited data for Frontage privatization and separation deal](https://longbridge.com/en/news/305814363.md)
- [Tigermed Issues Progress Update on Frontage Holdings Transactions](https://longbridge.com/en/news/305815201.md)
- [Hangzhou Tigermed Announces Extraordinary General Meeting](https://longbridge.com/en/news/305816569.md)
- [Frontage Announces Proposed Privatization and Asset Restructuring to Unlock Shareholder Value and Fuel Strategic Growth](https://longbridge.com/en/news/305707781.md)
- [Hangzhou Tigermed Files HKEX Next-Day Disclosure Return Announcing Share Buyback](https://longbridge.com/en/news/306242433.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**